Discover
EYPT
EyePoint Pharmaceuticals, Inc.
12.88
1 x 12.81
1 x 12.93
bid
ask
-
0.18
1.34%
09:31 AM
timesize
| Ytd | -29.53% | |
| 1y | 23.21% |
12.81
day range
13.05
9.40
52 week range
19.11
| Open | 12.81 | Prev Close | 13.05 | Low | 12.81 | High | 13.05 | Mkt Cap | 1.09B |
| Vol | 19.13K | Avg Vol | 1.19M | EPS | -3.50 | P/E | -3.73 | Forward P/E | 6.16 |
| Beta | 1.73 | Short Ratio | 11.30 | Inst. Own | 111.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 13.24 | 200-d Avg | 14.14 | 1yr Est | 40.50 |
| Income Statement | |||
| Total Revenue | 696.00K | ||
| Revenues (USD) | 696.00K | ||
| Cost of Revenue | 528.00K | ||
| Gross Profit | 168.00K | ||
| Operating Expenses | 87.39M | ||
| Research and Development Expense | 72.15M | ||
| Selling, General and Administrative Expense | 15.25M | ||
| Operating Income | -87.23M | ||
| Income Tax Expense | -50.00K | ||
| Net Income | -84.83M | ||
| Net Income Common Stock | -84.83M | ||
| Net Income Common Stock (USD) | -84.83M | ||
| Consolidated Income | -84.83M | ||
| Earnings per Basic Share | -0.99 | ||
| Earnings per Basic Share (USD) | -0.99 | ||
| Earnings per Diluted Share | -0.99 | ||
| Earning Before Interest & Taxes (EBIT) | -84.88M | ||
| Earning Before Interest & Taxes (USD) | -84.88M | ||
| Weighted Average Shares | 86.00M | ||
| Weighted Average Shares Diluted | 86.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 77.86M | ||
| Cash and Equivalents (USD) | 77.86M | ||
| Investments | 144.83M | ||
| Investments Current | 144.83M | ||
| Trade and Non-Trade Receivables | 1.16M | ||
| Current Assets | 249.50M | ||
| Property, Plant & Equipment Net | 29.26M | ||
| Total Assets | 288.22M | ||
| Total Debt | 20.23M | ||
| Current Liabilities | 37.46M | ||
| Debt Non-Current | 20.23M | ||
| Total Liabilities | 57.75M | ||
| Accumulated Retained Earnings (Deficit) | -1.19B | ||
| Accumulated Other Comprehensive Income | 802.00K | ||
| Shareholders Equity | 230.47M | ||
| Shareholders Equity (USD) | 230.47M | ||
| Assets Non-Current | 38.71M | ||
| Total Debt (USD) | 20.23M | ||
| Inventory | 1.25M | ||
| Liabilities Non-Current | 20.29M | ||
| Trade and Non-Trade Payables | 18.81M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 636.00K | ||
| Net Cash Flow from Financing | -2.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -24.11M | ||
| Capital Expenditure | -997.00K | ||
| Issuance (Purchase) of Equity Shares | 1.13M | ||
| Issuance (Repayment) of Debt Securities | -29.00K | ||
| Net Cash Flow from Investing | 59.05M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 60.05M | ||
| Net Cash Flow from Operations | -80.55M | ||
| Share Based Compensation | 11.64M | ||